SavedAdd your journal

Journals / Türk Geriatri Dergisi / 2019 / Cilt: 22 - Sayı: 1

PROFILE OF GERIATRIC PATIENTS IN A NEURO-OPHTHALMOLOGY OUTPATIENT CLINIC

Ayşe İlksen ÇOLPAK
Pages
48–55
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study contributed to the neuro-ophthalmological profile of Turkish geriatric patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: To determine the clinical profile of geriatric patients in a neuro-ophthalmology outpatient clinic of a tertiary center.Materials and Method: Retrospective evaluation of medical records from the institutional database, including patients aged ≥65 years who were treated by the same neuro-ophthalmologist, was performed.Results: A total of 99 (52 F, 47 M) geriatric patients were analyzed.
📊
Key Findings & Data:Mean age was 72.14±5.26 years.
💡
Conclusion & Impact:This study contributed to the neuro-ophthalmological profile of Turkish geriatric patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: To determine the clinical profile of geriatric patients in a neuro-ophthalmology outpatient clinic of a tertiary center.Materials and Method: Retrospective evaluation of medical records from the institutional database, including patients aged ≥65 years who were treated by the same neuro-ophthalmologist, was performed.Results: A total of 99 (52 F, 47 M) geriatric patients were analyzed. Mean age was 72.14±5.26 years. The most frequent complaint was visual loss (48.9%), followed by oculomotor abnormalities (38.7%). Thirty-eight of 48 patients had permanent visual loss, whereas 10 had transient visual loss. Patients with permanent visual loss were older than those with transient visual loss [mean ages of 73.05±5.85 and 68.5±2.84 years, respectively (p=0.022)]. Diplopia was the primary symptom, followed by ptosis in the oculomotor group.Conclusion: Neuro-ophthalmological diseases have many manifestations in the aging population. Physiological changes and risk factors associated with aging may lead to different complaints from young adults. This study contributed to the neuro-ophthalmological profile of Turkish geriatric patients.

🔖

Cite This Article

ÇOLPAK, A. İ. (2022). PROFILE OF GERIATRIC PATIENTS IN A NEURO-OPHTHALMOLOGY OUTPATIENT CLINIC. Türk Geriatri Dergisi, Cilt: 22 - Sayı: 1, 48–55. https://ajindex.com/articles/623630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Glasser A, Campbell MC. Presbyopia and the optical changes in the human crystalline lens with age. Vision Res 1998;38(2):209-29. (PMID:9536350)
  2. Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. West J Med. 1981;135(6):434-40. (PMID:7336713)
  3. Costello F. Inflammatory optic neuropathies. Continuum (Minneap Minn) 2014;20 (4 Neuroophthalmology): 816-37. (PMID:25099096)
  4. Crews JE, Chou CF, Zhang X, Zack MM, Saaddine JB. Health-related quality of life among people aged >/=65 years with self-reported visual impairment: findings from the 2006-2010 behavioral risk factor surveillance system. Ophthalmic Epidemiol 2014;21(5):287-96. (PMID:24955821)
  5. Evans JR, Fletcher AE, Wormald RP, Assessment MRCTo, Management of Older People in the C. Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community. Br J Ophthalmol 2004;88(3):365-70. (PMID:14977771)
  6. Yakin M, Yalniz-Akkaya Z, Sevim-Yakin S, Balta O, Ornek F. Ophthalmologic evaluation in geriatric patients: Assessment of consistency between patients’ complaints and ocular diagnoses. Arch Gerontol Geriatr 2017;68:90-6. (PMID:27710877)
  7. Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina 2014;34(1):115-22. (PMID:23632956)
  8. Vodopivec I, Rizzo JF, 3rd. Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford) 2018;57(suppl_2):ii63-ii72. (PMID:29986083)
  9. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122-8. (PMID:2202311)
  10. Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120(12):987-92. (PMID:8185147)
  11. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101(11):1779-85. (PMID:7800356)
  12. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995;273(8):625-32. (PMID:7844872)
  13. Murphy MA, Murphy JF. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthal